Traslational Cancer Drugs Pharma SL
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tcdpharma.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Traslational Cancer Drugs Pharma, SL
- Target Recruit Count
- 28
- Registration Number
- NCT01215864
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
News
No news found